+ All Categories
Home > Documents > Nanoparticles for Medical and Surgical Tumor Therapy

Nanoparticles for Medical and Surgical Tumor Therapy

Date post: 24-Feb-2016
Category:
Upload: ramya
View: 30 times
Download: 0 times
Share this document with a friend
Description:
Nanoparticles for Medical and Surgical Tumor Therapy . James M. Provenzale, MD. Departments of Radiology, Oncology and Biomedical Engineering Emory University School of Medicine and Department of Radiology Duke University Medical Center. Disclosures. Bayer Pharmaceuticals Advisory Board. - PowerPoint PPT Presentation
Popular Tags:
35
Nanoparticles for Medical and Surgical Tumor Therapy Departments of Radiology, Oncology and Biomedical Engineering Emory University School of Medicine and Department of Radiology Duke University Medical Center James M. Provenzale, MD
Transcript
Page 1: Nanoparticles for Medical and Surgical Tumor Therapy

Nanoparticles for Medical and Surgical Tumor Therapy

Departments of Radiology, Oncology and Biomedical EngineeringEmory University School of Medicine

and Department of Radiology

Duke University Medical Center

James M. Provenzale, MD

Page 2: Nanoparticles for Medical and Surgical Tumor Therapy

Disclosures

• Bayer Pharmaceuticals Advisory Board

• Research Funding from Bayer Pharmaceuticals and GE Healthcare

Page 3: Nanoparticles for Medical and Surgical Tumor Therapy

Aims

• Discuss medical uses of nanoparticles

• Show how nanoparticles and fluorescent molecules can be used for intraoperative imaging

Page 4: Nanoparticles for Medical and Surgical Tumor Therapy

• Chemotherapy or radiation therapy

Delivery Vehicles

• Other therapeutic drugs

• Gene therapy

• Materials for tissue engineering

Page 5: Nanoparticles for Medical and Surgical Tumor Therapy

• vesicles having a phospholipid bilayer membrane and an aqueous core

Liposomes

S. Leary. Neurosurgery 2006; 58:1009-1025

Page 6: Nanoparticles for Medical and Surgical Tumor Therapy

Liposomes

• Some liposomal chemotherapy formulations are already in clinical use

• Liposomal doxorubicin for Kaposi’s sarcoma and ovarian cancer

• Opportunity exists for targeted delivery

Page 7: Nanoparticles for Medical and Surgical Tumor Therapy

Targeted Imaging

tumor-targeted nanoparticles

C. Sun et al. Small 2008; 4:372-379

non-targeted nanoparticles

Subcutaneous implantation of glioma

Page 8: Nanoparticles for Medical and Surgical Tumor Therapy

S. Leary. Neurosurgery 2006; 58:1009-1025

Multi-functional Capability

Page 9: Nanoparticles for Medical and Surgical Tumor Therapy

Liposomes

• Can be made modified for delivery of contents solely at target-site

- disruption by ultrasound focused solely at the tumor

- disruption by heat applied at tumor site

- Responsive to local environmental conditions (e.g., pH, hypoxia)

Page 10: Nanoparticles for Medical and Surgical Tumor Therapy

Tissue Regeneration

G Silva. Nat Rev Neurosci 2006; 7:65-74

VM Tysseling-Mattiace. J Neurosci 2008; 28:3814-

3823

Page 11: Nanoparticles for Medical and Surgical Tumor Therapy

Multiple Sclerosis

Treatment: Decrease inflammatory response

Imaging: Targeting myelin debris

Nanoscaffold with axonal nutrients

Page 12: Nanoparticles for Medical and Surgical Tumor Therapy

• Thermal ablation

Therapeutic Uses

• Intra-operative guidance for improving surgical margins

Page 13: Nanoparticles for Medical and Surgical Tumor Therapy

E. Dickerson. Cancer Letters 2008; 269:57-66

Thermal Ablation

Control injection- saline, no

nanoparticles

Intravenous injection of gold nanoparticles

Intratumoral injection of gold nanoparticles

Mice bearing squamous cell carcinoma implants

Page 14: Nanoparticles for Medical and Surgical Tumor Therapy

Thermal Ablation

Signal proportional to number of particles within tumor

Intravenous injection of gold nanoparticles

Intratumoral injection of gold nanoparticles

Control injection- no nanoparticles

Page 15: Nanoparticles for Medical and Surgical Tumor Therapy

Thermal Ablation

Temperature change, 0 C Control injection,

no nanoparticles

Intratumoral injection of

gold nanoparticles

Page 16: Nanoparticles for Medical and Surgical Tumor Therapy

Tumor Growth after Ablation

Intravenous injection of

nanoparticles

Control group- no nanoparticles

Intratumoral injection of

nanoparticles

Page 17: Nanoparticles for Medical and Surgical Tumor Therapy

Findings after Thermal Ablation

L. Hirsch, et al. PNAS 2003; 100:13549-13554

Gross pathology

Silver staining for nanoparticles

Hematoxylin-eosin

Page 18: Nanoparticles for Medical and Surgical Tumor Therapy

• Ultrasmall paramagnetic iron oxide particles that can be used for imaging

Iron Oxide Particles

JH Lee et al. Angew Chem Int Ed Engl 2006; 45:8160-8162

• Already in human use

Page 19: Nanoparticles for Medical and Surgical Tumor Therapy

Intra-operative Imaging

Intra-operative 0.3T pre-resection

Intra-operative 0.3T post-resection

Page 20: Nanoparticles for Medical and Surgical Tumor Therapy

Intraoperative Imaging

Problems:• High cost of MR scanners

• Usually not portable

• Increase surgical time

• Do not provide real-time feedback

Page 21: Nanoparticles for Medical and Surgical Tumor Therapy

Real-time Intraoperative Imaging

• Fluorescent molecule as a contrast agent

• Laser excitation

• Passive accumulation in tumor hours after infusion

• Fluorescence depicted as color image or spectral wave form

Page 22: Nanoparticles for Medical and Surgical Tumor Therapy

Real-time Intraoperative Imaging

Page 23: Nanoparticles for Medical and Surgical Tumor Therapy

Improving Surgical Margins

• Subcutaneous breast cancer xenograft

• Resected tumor without optical imaging, to simulate conventional surgery

Page 24: Nanoparticles for Medical and Surgical Tumor Therapy

Improving Surgical Margins• Tumor cells had

been modified to contain luciferase enzyme

• After injection of luciferin, tumor could be detected using bioluminescence imaging

Page 25: Nanoparticles for Medical and Surgical Tumor Therapy

Positive Tumor Margin

Page 26: Nanoparticles for Medical and Surgical Tumor Therapy

Improving Surgical Margins Optical Imaging

Page 27: Nanoparticles for Medical and Surgical Tumor Therapy

Surgery in Large Animals Naturally occurring sarcoma in a dog

Resection 24 hours after infusion of fluorescent contrast agent

Page 28: Nanoparticles for Medical and Surgical Tumor Therapy

Optical Imaging of Tumor

Regions of high signal intensity At histology, all sites were + for tumor

Page 29: Nanoparticles for Medical and Surgical Tumor Therapy

Normal Tissue

Region of normal signal intensity

Page 30: Nanoparticles for Medical and Surgical Tumor Therapy

Normal Tissue

Region of normal signal intensity

Page 31: Nanoparticles for Medical and Surgical Tumor Therapy

Positive Tumor Margins

Region of high signal intensity

Page 32: Nanoparticles for Medical and Surgical Tumor Therapy

Imaging-Histology Correlation• Canine patient with thyroid carcinoma

• Black- low signal (negative)

• Blue-intermediate signal (negative)

• Red- high signal (positive)

Imaging Histology

• Normal tissue- square

• Tumor- circle

Page 33: Nanoparticles for Medical and Surgical Tumor Therapy

Imaging-Histology Correlation

• Black square- true negative

• Red circle- true positive

• Blue square- true negative

• Blue circle- false negative

Page 34: Nanoparticles for Medical and Surgical Tumor Therapy

Imaging-Histology Correlation

• 4 true negatives

• 4 true positives

• 1 false negative

Page 35: Nanoparticles for Medical and Surgical Tumor Therapy

Summary

• Nanoparticles, alone or with fluorescent contrast agents, can provide a means to improve surgical results

• Nanoparticles have capabilities to delivery drug therapy and materials for tissue regeneration


Recommended